JP2003532735A5 - - Google Patents

Download PDF

Info

Publication number
JP2003532735A5
JP2003532735A5 JP2001582349A JP2001582349A JP2003532735A5 JP 2003532735 A5 JP2003532735 A5 JP 2003532735A5 JP 2001582349 A JP2001582349 A JP 2001582349A JP 2001582349 A JP2001582349 A JP 2001582349A JP 2003532735 A5 JP2003532735 A5 JP 2003532735A5
Authority
JP
Japan
Prior art keywords
alkyl
group
compound according
halogen
furanosyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001582349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003532735A (ja
Filing date
Publication date
Priority claimed from GBGB0011203.7A external-priority patent/GB0011203D0/en
Application filed filed Critical
Publication of JP2003532735A publication Critical patent/JP2003532735A/ja
Publication of JP2003532735A5 publication Critical patent/JP2003532735A5/ja
Pending legal-status Critical Current

Links

JP2001582349A 2000-05-09 2001-05-08 抗ウイルスピリミジンヌクレオシド類 Pending JP2003532735A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0011203.7 2000-05-09
GBGB0011203.7A GB0011203D0 (en) 2000-05-09 2000-05-09 Chemical compounds
PCT/GB2001/002004 WO2001085749A1 (en) 2000-05-09 2001-05-08 Anti-viral pyrimidine nucleoside analogues

Publications (2)

Publication Number Publication Date
JP2003532735A JP2003532735A (ja) 2003-11-05
JP2003532735A5 true JP2003532735A5 (cg-RX-API-DMAC7.html) 2008-04-03

Family

ID=9891276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001582349A Pending JP2003532735A (ja) 2000-05-09 2001-05-08 抗ウイルスピリミジンヌクレオシド類

Country Status (14)

Country Link
US (1) US7019135B2 (cg-RX-API-DMAC7.html)
EP (1) EP1280813B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003532735A (cg-RX-API-DMAC7.html)
AT (1) ATE254132T1 (cg-RX-API-DMAC7.html)
AU (1) AU780879B2 (cg-RX-API-DMAC7.html)
CA (1) CA2406633A1 (cg-RX-API-DMAC7.html)
DE (1) DE60101223T2 (cg-RX-API-DMAC7.html)
DK (1) DK1280813T3 (cg-RX-API-DMAC7.html)
ES (1) ES2210153T3 (cg-RX-API-DMAC7.html)
GB (1) GB0011203D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ521877A (cg-RX-API-DMAC7.html)
PT (1) PT1280813E (cg-RX-API-DMAC7.html)
TR (1) TR200302313T4 (cg-RX-API-DMAC7.html)
WO (1) WO2001085749A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
ES2172303T3 (es) 1998-01-23 2002-09-16 Newbiotics Inc Agentes terapeuticos obtenidos por catalisis enzimatica.
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
IL147749A0 (en) 1999-07-22 2002-08-14 Newbiotics Inc Methods for treating therapy-resistant tumors
GB0009486D0 (en) 2000-04-17 2000-06-07 Univ Cardiff Chemical compounds
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
AU2003298658A1 (en) 2002-11-15 2004-06-15 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
GB0609178D0 (en) * 2006-05-09 2006-06-21 Univ Cardiff Novel compounds
US7951789B2 (en) 2006-12-28 2011-05-31 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
GB201111779D0 (en) * 2011-07-08 2011-08-24 Univ Cardiff Chemical compounds
US9403863B2 (en) 2011-09-12 2016-08-02 Idenix Pharmaceuticals Llc Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
AR089650A1 (es) 2011-10-14 2014-09-10 Idenix Pharmaceuticals Inc Fosfatos 3,5-ciclicos sustituidos de compuestos de nucleotido de purina y composiciones farmaceuticas para el tratamiento de infecciones virales
EP2852604B1 (en) 2012-05-22 2017-04-12 Idenix Pharmaceuticals LLC 3',5'-cyclic phosphoramidate prodrugs for hcv infection
WO2013177195A1 (en) 2012-05-22 2013-11-28 Idenix Pharmaceuticals, Inc. 3',5'-cyclic phosphate prodrugs for hcv infection
MD20140134A2 (ro) 2012-05-22 2015-04-30 Idenix Pharmaceuticals, Inc. Compuşi ai D-aminoacizilor pentru tratamentul bolilor hepatice
PT2861611T (pt) 2012-05-25 2016-10-11 Janssen Sciences Ireland Uc Nucleósidos de espirooxetano de uracilo
WO2014052638A1 (en) 2012-09-27 2014-04-03 Idenix Pharmaceuticals, Inc. Esters and malonates of sate prodrugs
ES2674980T3 (es) 2012-10-08 2018-07-05 Idenix Pharmaceuticals Llc Análogos de 2'-cloro nucleósidos para infección por VHC
WO2014066239A1 (en) 2012-10-22 2014-05-01 Idenix Pharmaceuticals, Inc. 2',4'-bridged nucleosides for hcv infection
US9211300B2 (en) 2012-12-19 2015-12-15 Idenix Pharmaceuticals Llc 4′-fluoro nucleosides for the treatment of HCV
WO2014137930A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. Thiophosphate nucleosides for the treatment of hcv
WO2014137926A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. 3'-deoxy nucleosides for the treatment of hcv
EP2970357B1 (en) 2013-03-13 2025-01-01 Idenix Pharmaceuticals LLC Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
EP2981542B1 (en) 2013-04-01 2021-09-15 Idenix Pharmaceuticals LLC 2',4'-fluoro nucleosides for the treatment of hcv
EP3004130B1 (en) 2013-06-05 2019-08-07 Idenix Pharmaceuticals LLC. 1',4'-thio nucleosides for the treatment of hcv
US20150037282A1 (en) 2013-08-01 2015-02-05 Idenix Pharmaceuticals, Inc. D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
EP3131914B1 (en) 2014-04-16 2023-05-10 Idenix Pharmaceuticals LLC 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62255499A (ja) * 1986-04-28 1987-11-07 Teijin Ltd 螢光性ヌクレオシド又はヌクレオチド
GB9708611D0 (en) * 1997-04-28 1997-06-18 Univ Cardiff Chemical compounds
GB9716231D0 (en) * 1997-07-31 1997-10-08 Amersham Int Ltd Base analogues

Similar Documents

Publication Publication Date Title
JP4959900B2 (ja) 抗ウイルスピリミジンヌクレオシド類
JP2004506606A5 (cg-RX-API-DMAC7.html)
JP2003522101A5 (cg-RX-API-DMAC7.html)
JP2005511531A5 (cg-RX-API-DMAC7.html)
JP2004002414A5 (cg-RX-API-DMAC7.html)
JP2005510476A5 (cg-RX-API-DMAC7.html)
CA2545427A1 (en) Selective kinase inhibitors
TR200102490T2 (tr) Fenil ve piridinil türevleri
MXPA04003532A (es) Pirimidinonas como receptor 1 de la hormona concentradora de melanina.
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
WO2005084192A3 (en) Novel 2’-c-methyl nucleoside derivatives
JP2009502801A5 (cg-RX-API-DMAC7.html)
JP2008526999A5 (cg-RX-API-DMAC7.html)
EP2305642A3 (en) Bis(thio-hydrazide amide) salts for treatment of cancers
JP2003532735A (ja) 抗ウイルスピリミジンヌクレオシド類
JP2002520282A5 (cg-RX-API-DMAC7.html)
JP2006515339A5 (cg-RX-API-DMAC7.html)
MXPA03006163A (es) Derivados de purina como antagonistas de receptores purinergicos.
EP1125936A3 (en) Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases
JP2005527542A5 (cg-RX-API-DMAC7.html)
JP2004503564A5 (cg-RX-API-DMAC7.html)
JP2002525323A5 (cg-RX-API-DMAC7.html)
LU91178I2 (fr) Emtricitabine / Tenofovir Disoproxil et ses dérivés pharmaceutiquement acceptables (TRUVADA).
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
JP2002506864A5 (cg-RX-API-DMAC7.html)